Bluebird Bio, TC BioPharm Partner to Develop Gamma Delta CAR T-cell Therapy Candidates – Immuno-Oncology News
|
Bluebird Bio, TC BioPharm Partner to Develop Gamma Delta CAR T-cell Therapy Candidates
Immuno-Oncology News Bluebird bio and TC BioPharm recently announced a new partnership to develop gamma delta CAR T-cell product candidates for the treatment of cancer. The collaboration and licensing agreement were established to advance TC BioPharm's CAR-engineered gamma … |
